For: | Ward MG, Irving PM, Sparrow MP. How should immunomodulators be optimized when used as combination therapy with anti-tumor necrosis factor agents in the management of inflammatory bowel disease? World J Gastroenterol 2015; 21(40): 11331-11342 [PMID: 26525434 DOI: 10.3748/wjg.v21.i40.11331] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v21/i40/11331.htm |
Number | Citing Articles |